Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Moodys
Harvard Business School
Mallinckrodt
Boehringer Ingelheim

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP. (D.N.J. 2017)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-08-08
Court District Court, D. New Jersey Date Terminated 2018-11-13
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Cathy L. Waldor
Parties MERCK SHARP & DOHME CORP.; SANOFI WINTHROP INDUSTRIE; SANOFI-AVENTIS DEUTSCHLAND GMBH; SANOFI-AVENTIS U.S. LLC
Patents 5,948,751; 6,034,054; 6,248,363; 6,309,663; 6,960,561; 7,476,652; 7,713,930
Attorneys CHRISTINE INTROMASSO GANNON; ELIZABETH J. SHER; KATELYN O'REILLY; LIZA M. WALSH; RICHARD H. BROWN , III
Firms Day Pitney LLP; Day Pitney, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-08-08 1 patent is extended or adjusted under 35 5,948,751 A … 5,948,751 A 9/1999 Kirner et al. (21) Appl… This is an action for patent infringement and arises under the patent laws of the United States,… PATENTS-IN-SUIT 13. On January 13, 2009, United States Patent No. 7,476,652 …United States Patent and Trademark Office (“PTO”). A true and correct copy of the ’652 Patent is attached External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
AstraZeneca
McKesson
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.